Search filters

Filters
Clear All

Phase

  • 7
  • 1
  • 4
  • 2
  • 315
  • 22
  • 32
  • 356
  • 384
  • 131

Found 410 ctsi-central-admin trials

A listing of ctsi-central-admin medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

18 - 25
All genders
The purpose of this study is to examine the effects of cooperative and competitive video game play on perceived friendship quality.
18 - 27
All genders
The purpose of this study is to better understand opioid misuse among young people.
18 - 65
All genders
The purpose of this study is to teach us more about why some people often experience headaches after having a mild traumatic brain injury. We need individuals who have NOT experienced a traumatic brain injury.
100 or below
All genders
The purpose of this study is to find whether MRI of the brain can help in identifying infants who will have withdrawal symptoms after prenatal exposure to opioids.
18 - 100
Female
The purpose of this research study is to determine how well neratinib, by itself or together with Fulvestrant, works in treating breast cancer that has spread to other parts of the body. We will also be looking at the side effects associated with this combination of drugs.
100 or below
All genders
The purpose of this study is to gain a better understanding of metabolic bone diseases through DNA analysis.
30 or below
All genders
This trial studies how well cisplatin and combination chemotherapy works in treating children and young adults with hepatoblastoma or liver cancer after surgery.
18 - 100
All genders
The purpose of this study is to compare the effect of RCHOP/enzastaurin versus R-CHOP on overall survival (OS) in treatment-naive, high-risk subjects with Diffuse Large B-Cell Lymphoma (DLBCL) who possess the DGM1 biomarker.
18 - 100
All genders
The purpose of this study is to estimate how many patients currently smoke tobacco who are diagnosed with breast, colon, and prostate cancer, to understand what patients know about the harms of continuing to smoke, and to learn about any previous efforts to quit.
18 - 70
All genders
Prospective, interventional multicenter study evaluating adoptive cell therapy (ACT) with Lifileucel infusion (LN-144) followed by interleukin 2 (IL-2) after a nonmyeloablative lymphodepletion (NMA-LD) preparative regimen.
181 - 190 of 410